Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Journal of Cellular and Molecular Medicine
|
December 25, 2024
A Systematic Review of the Molecular Mechanisms Involved in the Association Between PCOS and Endometrial and Ovarian Cancers
M Zanjirband, M H Nasr-Esfahani, N J Curtin, et al.
Biochimie
|
January 1, 1995
The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapy
R J Griffin, N J Curtin, D R Newell, et al.
British Journal of Cancer
|
December 17, 2009
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
N Johnson, J Bentley, L-Z Wang, et al.
British Journal of Cancer
|
October 1, 1995
Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors
S Boulton, L C Pemberton, J K Porteous, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 1998
Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro
E Marshman, D R Newell, A H Calvert, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP)
R J Griffin, S Srinivasan, K Bowman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2001
In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity
P G Smith, H D Thomas, H C Barlow, et al.
British Journal of Cancer
|
February 22, 2014
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
J Murray, H Thomas, P Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2000
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines
C A Delaney, L Z Wang, S Kyle, et al.
British Journal of Cancer
|
May 29, 2014
Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples
M J Patterson, R E Sutton, I Forrest, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Journal of Cellular and Molecular Medicine
|
December 25, 2024
A Systematic Review of the Molecular Mechanisms Involved in the Association Between PCOS and Endometrial and Ovarian Cancers
M Zanjirband, M H Nasr-Esfahani, N J Curtin, et al.
Biochimie
|
January 1, 1995
The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapy
R J Griffin, N J Curtin, D R Newell, et al.
British Journal of Cancer
|
December 17, 2009
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
N Johnson, J Bentley, L-Z Wang, et al.
British Journal of Cancer
|
October 1, 1995
Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors
S Boulton, L C Pemberton, J K Porteous, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 1998
Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro
E Marshman, D R Newell, A H Calvert, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP)
R J Griffin, S Srinivasan, K Bowman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2001
In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity
P G Smith, H D Thomas, H C Barlow, et al.
British Journal of Cancer
|
February 22, 2014
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
J Murray, H Thomas, P Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2000
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines
C A Delaney, L Z Wang, S Kyle, et al.
British Journal of Cancer
|
May 29, 2014
Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples
M J Patterson, R E Sutton, I Forrest, et al.
Page
of 5